CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
&AI›
Library
&AI

&AI

Collaborative workspace for patent litigators.

HQ
San Francisco, CA, US
Accelerator
Y Combinator logoY CombinatorS24
Loading
Overview
Compare
Fundraising
Employees
Library

&AI - Library

Official pages and third-party coverage in one index.

tryandai.com·24 items across 23 mapped pages · Crawled Sep 24, 2026·

Topics

Publication type

Content origin
Row density

Official pages and third-party coverage in one index

Product

6 pages
  1. Business Development/product/business-development

    Opportunities is &AI's real-time feed of patent litigation filings, personalized to you and your team with memory of your prior work and how you like to pitch.

  2. Claim Charts/product/claim-charts

    Generate precise patent invalidity claim charts and evidence-of-use charts, with dozens of formatting settings that make your chart exports trial-ready.

  3. Infringement Detection/product/infringement-detection

    Mine portfolios for infringement targets, search product documentation, and generate evidence-of-use charts and (non)infringement analysis at scale.

  4. Invalidity Analysis/product/invalidity-analysis

    Discover prior art, generate claim charts, and draft §102, §103, and §112 arguments—grounded in claim construction and full prosecution history.

Blog

6 pages
  1. Blog/blog

    Stay up to date with the latest news, insights, and updates from &AI—the AI workspace for patent litigation.

  2. How Patent Litigators Draft Submission Ready Claim Charts/blog/how-patent-litigators-draft-submission-ready-claim-charts

    &AI's 65 chart-formatting controls—limitation labels, Bluebook citations, screenshots, and layout—take claim charts from export to filing with no edits in Word.

  3. Novo Nordisk Sues Hims for Patent Infringement Over Compounded Semaglutide/blog/novo-nordisk-sues-hims-for-patent-infringement-over-compounded-semaglutide

    Novo Nordisk dismissed its Hims semaglutide patent lawsuit without prejudice after a new agreement. See what was alleged and what remains unresolved.

  4. Public Access Announcement/blog/public-access-announcement

    &AI is now generally available with transparent, credit-based pricing—built for patent litigation workflows like search, claim charts, drafting, and tables.

Pricing

1 page
  1. Pricing/pricing

    Choose the right credit model for your patent litigation workflow. Pay as you go, Pro, and Enterprise pricing options available.

Comparison

6 pages
  1. And &AI vs Ip Copilot/compare/and-ai-vs-ip-copilot

    &AI vs IP Copilot: how a litigation work-product workspace compares to an IP-management platform that also offers prior art and infringement search.

  2. And &AI vs Iprally/compare/and-ai-vs-iprally

    &AI vs IPRally: how a litigation-built workspace compares to an AI-native patent search and intelligence platform on prior art, invalidity, and trial-ready charts.

  3. And &AI vs Nlpatent/compare/and-ai-vs-nlpatent

    &AI vs NLPatent: how a litigation-built workspace compares to a patent-specific AI search and analysis platform on prior art, invalidity, and trial-ready charts.

  4. And &AI vs Patlytics/compare/and-ai-vs-patlytics

    &AI vs Patlytics for patent litigation: how a litigation-built workspace compares to a full patent-lifecycle platform on prior art, invalidity, charts, and infringement.

About

1 page
  1. Company/company

    Meet the team behind &AI, the AI workspace for patent litigation. Founded by MIT engineers, we help in-house counsel and litigators scale patent expertise.

Homepage

1 page
  1. Homepage/

    The patent litigation AI workspace for in-house counsel and litigation teams—claim charts, prior art search, and invalidity analysis at machine scale.

Privacy

1 page
  1. Privacy/privacy

    Read the &AI privacy policy: how we collect, use, and protect your data, our zero-data-retention and no-training commitments, and your privacy rights.

Terms & Conditions

1 page
  1. Terms/terms

    Read the &AI terms of service governing use of the &AI patent litigation platform, including account, subscription, and acceptable-use terms.

Not yet classified

1 page
  1. tryandai.com/

    The patent litigation AI workspace for in-house counsel and litigation teams—claim charts, prior art search, and invalidity analysis at machine scale.